Watchman Group’s SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2022
Q1 | – | Sell |
-3,820
| Closed | -$428K | – | 87 |
|
2021
Q4 | $428K | Sell |
3,820
-1,140
| -23% | -$128K | 0.22% | 61 |
|
2021
Q3 | $624K | Sell |
4,960
-730
| -13% | -$91.8K | 0.4% | 52 |
|
2021
Q2 | $770K | Sell |
5,690
-450
| -7% | -$60.9K | 0.45% | 57 |
|
2021
Q1 | $833K | Sell |
6,140
-1,860
| -23% | -$252K | 0.51% | 54 |
|
2020
Q4 | $1.13M | Sell |
8,000
-210
| -3% | -$29.6K | 0.75% | 52 |
|
2020
Q3 | $914K | Sell |
8,210
-850
| -9% | -$94.6K | 0.68% | 53 |
|
2020
Q2 | $1.01M | Hold |
9,060
| – | – | 0.84% | 50 |
|
2020
Q1 | $702K | Sell |
9,060
-660
| -7% | -$51.1K | 0.72% | 48 |
|
2019
Q4 | $924K | Buy |
+9,720
| New | +$924K | 0.69% | 50 |
|